Improving Dosing of Common Antibiotics used in Critically Ill Australian Indigenous Patients

改善澳大利亚原住民重症患者常用抗生素的剂量

• 批准号: nhmrc : 1074523
• 负责人: Mr Danny Tsai
• 金额: $ 6.54万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/improving-dosing-common-indigenous-patients/455604
• 关键词: Improving; Dosing; Common; Antibiotics; used

Optimal antibiotic dosing in patients in the intensive care unit saves lives. However, the way antibiotics move through the body of an intensive care unit patient can be different to other patients. Therefore, research that identifies specific dosing for these patients is essential. Further to this, no research in an Indigenous population is available. The aim of this research is to address this gap by developing optimal antibiotic doses for Indigenous Australians in the intensive care unit.

重症监护室患者的最佳抗生素剂量可以挽救生命。然而，抗生素在重症监护病房患者体内的移动方式可能与其他患者不同。因此，确定这些患者的具体剂量的研究至关重要。除此之外，还没有针对土著居民的研究。这项研究的目的是通过为重症监护病房的澳大利亚原住民制定最佳抗生素剂量来解决这一差距。